Fluorodopa F 18 vs Osimertinib
Fluorodopa F 18 vs Osimertinib: Overview
This comparison examines the pharmacological differences between Fluorodopa F 18 and Osimertinib.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Pharmacokinetics
Half-life: Osimertinib — 48 hours.
Chemical Properties
Molecular Formula: Osimertinib — C28H33N7O2.
Molecular Weight: Osimertinib — 499.6050 g/mol.
Type: Fluorodopa F 18 — Small molecule; Osimertinib — Small molecule.